Evusheld
Concerns of Evusheld Lacking Protection Against Omicron XBB.1.5
The FDA does not expect Evusheld to neutralize XBB.1.5, a new emerging Omicron subvariant.
JANUARY 10, 2023
Evusheld Lacks Variant Protection, FDA Says
Evusheld (AstraZeneca) may not be effective against COVID-19 variants, according to the FDA.
OCTOBER 6, 2022
Load more